We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
How investigators and sponsors should manage clinical trials during COVID-19
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed.
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
The MHRA is ready to provide any assistance for clinical trials applications submitted for COVID-19
Details of dates when trials are likely to take place at the Chancery division of the High Court.
Actions that trial sponsors should consider to build resilience into clinical trial design
How to use a randomised controlled trial to evaluate your digital health product.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
How to use a micro-randomised trial to evaluate your digital health product.
How to use a factorial randomised controlled trial to evaluate your digital health product.
Guidance and reports on the Department for Transport's trial of longer semi-trailers for articulated goods vehicles.
How to carry out a clinical trial to apply for a marketing authorisation, manage your authorisation and report safety issues.
This guidance identifies common issues with validation and assessment of clinical trial applications and how to avoid them.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
A complete list of 5G projects involved in the 5G Testbeds and Trials Programme
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).